Telegenetics and COVID 19: Through the Pandemic and Beyond




COVID-19, geneticist, pandemic, telemedicine


Introduction - The COVID 19 pandemic led to restrictions on the conventional ways of healthcare delivery. Telemedicine provided a viable solution that was in line with the social distancing policies imposed to minimize disease transmission. This demanded physicians adapt to new ways of healthcare delivery. We surveyed geneticists across the country to determine their experience and to ascertain if telegenetics will be a lasting change.

Materials and Methods - A 23 item standardized survey was distributed to various US-based geneticists via email and other social media platforms focusing on their experience of providing care via telemedicine.

Results - We received 69 responses from physicians across 26 states. Of these, 91% practiced in academia. 70% responded that pediatric genetics takes up more than 50% of their practice. 68% had over 50% of their practice switch to telemedicine. 77% felt they could provide adequate care via telemedicine and 94% of providers would like to continue telemedicine post-pandemic.

Conclusion - The future of telemedicine looks promising as the majority of clinicians would like to routinely use telemedicine post-pandemic. Uniform guidelines for use of telemedicine in genetics may need to be proposed by professional societies and supported by federal laws. 


Download data is not yet available.


WHO. Director General’s opening remarks at the media briefing on COVID-19. 2020 Mar 11 [cited May 2021]. Available from:

Shur N, Atabaki SM, Kisling MS, Tabarani A, Williams C, Fraser JL, et al. Rapid deployment of a telemedicine care model for genetics and metabolism during COVID-19. Am J Med Genet A. 2021; 185(1):68–72.

Wamsley CE, Kramer A, Kenkel JM, Amirlak B. Trends and challenges of telehealth in an academic institution: the unforeseen benefits of the COVID-19 global pandemic. Aest Surg J. 2020;41(1):109–18.

Trettel A, Eissing L, Augustin M. Telemedicine in dermatology: findings and experiences worldwide – a systematic literature review. J Eur Acad Dermatol Venereol2018;32(2):215–24.

Waller M, Taylor L, Portnoy J. The medical virtualist: is pediatric patient care using telemedicine, a new specialty? Pediatr Ann 2019;48(6):e243–8.

Wosik J, Fudim M, Cameron B, Gellad ZF, Cho A, Phinney D, et al. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc 2020;27(6):957–62.

Hilgart JS, Hayward JA, Coles B, Iredale R. Telegenetics: a systematic review of telemedicine in genetics services. Genet Med 2012;14(9):765–76.

Zierhut HA, MacFarlane IM, Ahmed Z, Davies J. Genetic counselors’ experiences and interest in telegenetics and remote counseling. J Genet Couns 2018;27(2):329–38.

Nesbitt TS. The evolution of telehealth: where have we been and where are we going? In: Board on Health Care Services, Institute of Medicine. The role of telehealth in an evolving health care environment: workshop summary. Washington, DC: National Academies Press; 2012, pp. 11–16. [cited October 2021]. Available from:

Sood S, Mbarika V, Jugoo S, Dookhy R, Doarn CR, Prakash N, et al. What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings. Telemed J E Health 2007;13(5):573–90.

Muller KI, Alstadhaug KB, Bekkelund SI. Headache patients’ satisfaction with telemedicine: a 12-month follow-up randomized non-inferiority trial. Eur J Neurol 2017;24(6):807–5.

Avidor D, Loewenstein A, Waisbourd M, Nutman A. Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review. Cost Eff Resour Alloc2020;18:16.

Ananthakrishnan AN, Singh S. The doctor will call you now! Telemedicine in the midst of a pandemic. Clin Gastroenterol Hepatol 2020;18(8):1688–90.

Hilgart JS, Hayward JA, Coles B, Iredale R. Telegenetics: a systematic review of telemedicine in genetics services. Genet Med 2012; 14(9):765–76.

Stalker HJ, Wilson R, McCune H, Gonzalez J, Moffett M, Zori RT. Telegenetic medicine: improved access to services in an underserved area. J Telemed Telecare 2006;12(4):182–5.

Garattini L, Badinella Martini M, Zanetti M. More room for telemedicine after COVID-19: lessons for primary care? Eur J Health Econ 2021;22(2):183–6.

Hall JL, McGraw D. For telehealth to succeed, privacy and security risks must be identified and addressed. Health Affairs 2014;33(2):216–21.

Lea DH. A new world view of genetics service models. Online J Issues Nurs 2000; 5(3):5.

European Society of Human Genetics’ PPPC. Provision of genetic services in Europe: current practices and issues. Eur J Hum Genet 2003;11(2):S13–48.

Hawkins AK, Hayden MR. A grand challenge: providing benefits of clinical genetics to those in need. Genet Med 2011;13(3):197–200.

Tuckson RV, Edmunds M, Hodgkins ML. Telehealth. N Engl J Med 2017;377(16):1585–92.



How to Cite

Ravi, S., Kochhar, A., & Dhamija, R. . (2021). Telegenetics and COVID 19: Through the Pandemic and Beyond. Telehealth and Medicine Today, 6(4).



Original Clinical Research

Similar Articles

You may also start an advanced similarity search for this article.